Skip to main content
. 2013 Aug 12;10(5):199–209. doi: 10.4314/ajtcam.v10i5.1

Table 2.

Urine parameters before and after treatment were checked in Wu-ling-san formula or placebo group.

Wu-ling-san group Placebo group P value
(% of change)
Pretreatment Post-treatment % of change Pretreatment Post-reatment % of change
Urine volume(ml/day) 2485.7 ± 386.5 2796.4 ± 525.7 13.9% 2732.1 ± 797.9 2521.4 ± 762.7 −5.7% 0.02*
Urine Ca (mg/day) 249.5 ± 132.2 302.1 ± 106.5 44.6% 266.3 ± 101.6 415.1 ± 290.7 62.7% 0.62
Urine UA (mg/day) 749.6 ± 336.6 893.5 ± 334.1 27.6% 760.6 ± 246.2 849.3 ± 478.4 9.5% 0.22
Urine Cr (mg/dl) 59.1 ± 21.7 71.1 ± 24.4 42.9% 66.0 ± 33.5 80.4 ± 27.6 36.6% 0.84
Urine PH 6.6 ± 0.6 6.5 ± 0.7 −0.02% 6.3 ± 0.8 6.3 ± 0.7 0.6% 0.91
24hr Urine Ccr (ml/min) 89.2 ± 26.4 107.5 ± 30.9 26.2% 133.4 ± 37.1 114.1 ± 44.0 14.5% 0.53

Data presented as mean ±SD

*

Percentage of change between groups P < 0.05 (independent t-test)